Multi-Center observational study to evaluate the relationship between the status of lung/oral flora and therapeutic efficacy of afatinib for EGFR mutated non-small cell lung cancers
Not Applicable
Recruiting
- Conditions
- lung cancer
- Registration Number
- JPRN-UMIN000036622
- Lead Sponsor
- Hirosaki Universitiy Graduate school of medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1 Duplicate cancer of active 2 Autoimmune disease 3 Severe lung disease(ILD IPF) 4 Infections requiring systemic treatment 5 Serious psychiatric disorders 6 Symptomatic brain metastasis 7 Control poor diabetes 8 Control poor disease(heart disease lung disease liver disease kidney disease) 9 Active Hepatitis (type B virus or type C virus) 10 Systemic steroid administration 11 Pregnant women lactating women or women with a positive pregnancy test A woman without intention to contraception A woman wishing to become pregnant or breastfeeding 12 Drug hypersensitivity 13 Cases the attending physician determines that inappropriate to participate in the study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method